LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 9.16 | 771.67 | 1086 | 1138 | 0.9539 | 0.8386 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 11.56 | 771.67 | 1118 | 1280 | 0.8730 | 0.6608 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 11.56 | 771.67 | 1234 | 1280 | 0.9636 | 0.9010 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 13.78 | 771.67 | 1199 | 1459 | 0.8214 | 0.6148 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 13.78 | 771.67 | 1349 | 1459 | 0.9241 | 0.8356 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.00 | 771.67 | 1255 | 1585 | 0.7916 | 0.5970 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.00 | 771.67 | 1430 | 1585 | 0.9019 | 0.8108 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.22 | 771.67 | 1303 | 1741 | 0.7483 | 0.5623 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.22 | 771.67 | 1461 | 1741 | 0.8390 | 0.7223 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.44 | 771.67 | 1324 | 1910 | 0.6929 | 0.5109 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.44 | 771.67 | 1493 | 1910 | 0.7813 | 0.6562 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.66 | 771.67 | 1366 | 2141 | 0.6379 | 0.4738 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.66 | 771.67 | 1540 | 2141 | 0.7191 | 0.5988 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.89 | 771.67 | 1460 | 2397 | 0.6089 | 0.4768 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.89 | 771.67 | 1616 | 2397 | 0.6740 | 0.5713 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.11 | 771.67 | 1514 | 2675 | 0.5660 | 0.4561 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.11 | 771.67 | 1700 | 2675 | 0.6355 | 0.5533 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.33 | 771.67 | 1593 | 2939 | 0.5420 | 0.4560 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.33 | 771.67 | 1796 | 2939 | 0.6110 | 0.5493 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.55 | 771.67 | 1658 | 3196 | 0.5187 | 0.4521 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 31.55 | 771.67 | 1893 | 3196 | 0.5922 | 0.5490 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.78 | 771.67 | 1737 | 3499 | 0.4963 | 0.4506 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.78 | 771.67 | 1970 | 3499 | 0.5629 | 0.5368 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.00 | 771.67 | 1872 | 3884 | 0.4819 | 0.4624 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.00 | 771.67 | 2046 | 3884 | 0.5267 | 0.5192 | MN20160304_L01 | L17 |